Our analytics tools can take your healthcare data, help you focus your efforts on who could benefit most from testing, and produce a potential return on investment drawn from one of the largest databases available. Analytics for one group of retirees in the U.S. showed 83% taking medications with PGx implications and, through testing, a 63% rate of recommended medication therapy changes. After implementation, the group saw a 29% reduction in hospitalizations and 18% reduction in pharmacy expenses.
RxGenomix has a comprehensive program to help any group access and put pharmacogenomic testing to work for them. We have established lab relationships, a network of pharmacists, an in-depth training program, and a variety of marketing and support tools to help any program succeed.
By integrating pharmacogenomics-trained pharmacists, we make the connection between the healthcare providers and the medication experts and put that expertise to work for you. This application has been shown to save an average of more than $5000 per year for patients diagnosed with depression and/or anxiety, as well as increasing productivity and presenteeism in the workplace.